People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Investment Vehicle, Pharmaceuticals, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Helix Holdings I, LLC | — | Investment Vehicle | Series D+ | $235.0M | $764.9M | 2021 |
| Forty Seven, Inc. | — | Pharmaceuticals | Series C | $109.1M | $2.6B | 2015 |
| Virobay Inc | — | Other Health Care | Series B | $28.3M | $398.8M | 2009 |
| Merganser Biotech, Inc. | — | Biotechnology | Series A | $21.1M | $473.5M | 2015 |
| Xoft Inc | — | Other Health Care | Series A | $12.1M | $16.2M | 2009 |
Jeffrey Bird at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Bird on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Topper | 1 | 12 |
| Noah Knauf | 1 | 9 |
| John Friedman | 1 | 9 |
| Michael Klein | 1 | 9 |
| Jonathan MacQuitty | 1 | 7 |
| JEFF BIRD | 1 | 7 |
| David Singer | 1 | 7 |
| Heather Preston | 1 | 6 |
| Christopher Schaepe | 1 | 6 |
| Jeffrey W. Bird | 1 | 6 |
| DENNIS HENNER | 1 | 5 |
| Eric Jensen | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Markus Goebel | 1 | 4 |
| Arda Minocherhomjee | 1 | 4 |
| Brian MacDonald | 1 | 4 |
| Robert Booth | 1 | 4 |
| Justin Kao | 1 | 4 |
| Thomas Dietz | 1 | 4 |
| James Lu | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.